Novonesis (NVZMY) Price & Analysis

Novonesis A/S - Adr released its earnings results on May 08, 2025. The company reported $0.474 earnings per share for the quarter, beating the consensus estimate of $0.437 by $0.037.

Is Novonesis A/S - Adr overvalued?

According to Wall Street analysts Novonesis A/S - Adr’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Novonesis A/S - Adr pay dividends?

Novonesis A/S - Adr pays a Semiannually dividend of $0.614 which represents an annual dividend yield of 1.38%. See more information on Novonesis A/S - Adr dividends here

What is Novonesis A/S - Adr’s EPS estimate?

Novonesis A/S - Adr’s EPS estimate is 0.67.

How many shares outstanding does Novonesis A/S - Adr have?

Novonesis A/S - Adr has 414,555,050 shares outstanding.

What happened to Novonesis A/S - Adr’s price movement after its last earnings report?

Novonesis A/S - Adr reported an EPS of $0.474 in its last earnings report, beating expectations of $0.437. Following the earnings report the stock price went up 3.546%.

Which hedge fund is a major shareholder of Novonesis A/S - Adr?

Currently, no hedge funds are holding shares in NVZMY

Novonesis Stock Smart Score

Neutral

Company Description

Novonesis A/S - Adr

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Novonesis (NVZMY) Earnings & Revenues

Historic Earnings Reports

NVZMY Company Deck

NVZMY Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects a strong start to 2025 with robust organic sales growth and profitability improvements, despite challenges from market exits and currency headwinds. The company's diversified portfolio and strategic acquisitions position it well for future growth.View all NVZMY earnings summaries